Drug intelligence / Profile preview

Jiuwei Xifeng Granules

Development stage
Phase 4
Lead developer
Lianyungang Kanion
Administration
Oral
01

Overview

Jiuwei Xifeng Granules is a Traditional Chinese Medicine (TCM) formulation developed by Jiangsu Kanion Pharmaceutical for the treatment of pediatric tic disorders, including Tourette syndrome and chronic motor or vocal tic disorders. The formulation is designed to address the TCM patterns of kidney yin deficiency and internal stirring of liver wind. A specific variant of the granules has been studied where dragon bone (Os Draconis) is replaced with oyster shell (Concha Ostreae) to evaluate efficacy and safety in children with mild-to-moderate tic disorders. Clinical trials have also explored its use in related conditions such as attention deficit hyperactivity disorder (ADHD).

Brand names
Jiu-Wei-Xi-Feng granulesKangyuan Jiuwei Xifeng Keli
Other names
Jiuwei Xifeng Keli九味熄风颗粒Jiuwei Xifeng Granules (oyster-based)
02

Targets

DRD1 (Dopamine D1 Receptor)DRD2 (Dopamine D2 Receptor)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))KCNH2 (Voltage-gated potassium channel subfamily H member 2)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on Jiuwei Xifeng Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiuwei Xifeng Granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call